Back to Journals » Therapeutics and Clinical Risk Management » Volume 5
Review
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,300 | Dovepress* | 14,300+ | 2,327 | 16,627 | |
Totals | 14,300 | 2,327 | 16,627 | ||
*Since 25 September 2009 +Since July 2016 |
View citations on Google Scholar